6533b86ffe1ef96bd12cde85

RESEARCH PRODUCT

Infected osteoradionecrosis of the mandible: follow-up study suggests deterioration in outcome for patients with Actinomyces-positive bone biopsies.

Torsten HansenC.j. KirkpatrickWilfried WagnerMartin Kunkel

subject

AdultMalemedicine.medical_specialtyOsteoradionecrosismedicine.medical_treatmentMandibleGastroenterologyActinomycosisInternal medicineBiopsymedicineActinomycesHumansMandibular DiseasesAgedbiologymedicine.diagnostic_testbusiness.industryMandibleFollow up studiesActinomycetaceaeMiddle Agedbiology.organism_classificationmedicine.diseaseSurgeryRadiation therapyExact testLogistic ModelsTreatment OutcomeOtorhinolaryngologyOsteoradionecrosisSurgeryFemaleOral SurgerybusinessActinomycesFollow-Up Studies

description

Abstract Infected osteoradionecrosis (IORN) is one of the major complications of oral cancer radiotherapy. Recent studies showed a high prevalence of Actinomyces in IORN. In this study, the clinical follow up of IORN patients ( n  = 25; 20 male, 5 female) with regard to Actinomyces detection in the mandible was analyzed. Within 1.6–119 months of follow up, disease control was achieved in almost 90% of the patients with Actinomyces -negative bone biopsies, but only in 25% of the Actinomyces -positive group. The presence of Actinomyces was associated with a significantly higher risk of treatment failure ( P  = 0.004; Fisher's exact test). This held true when the data were controlled for ‘extent of bone destruction’, ‘type of surgery’ and ‘soft-tissue closure’ in a logistic regression analysis ( P  = 0.018; Wald test). Since Actinomyces was detected in a significant number of patients with non-healing mucosal defects, this microbe may promote the persistence of chronic non-healing inflammatory processes. Actinomyces positivity defines a subpopulation with a clinically deteriorated course of mandibular IORN.

10.1016/j.ijom.2006.08.006https://pubmed.ncbi.nlm.nih.gov/17049813